U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

RSV LID .DELTA.M2-2 VACCINE

MORE DETAILS

N3W9SRQ6W6

structurally diverse
Status:
Investigational
Source:
NCT02237209: Phase 1 Interventional Completed Respiratory Syncytial Virus Infections
(2014)
Source URL:
https://clinicaltrials.gov/ct2/show/NCT02237209
Class:
STRUCTURALLY DIVERSE

HUMAN RESPIRATORY SYNCYTIAL VIRUS SUBGROUP A

MORE DETAILS

5LLJ3ZKP16

structurally diverse
Status:
Other
Class:
STRUCTURALLY DIVERSE

HUMAN RESPIRATORY SYNCYTIAL VIRUS SUBGROUP B

MORE DETAILS

96U226U1LZ

structurally diverse
Status:
Other
Class:
STRUCTURALLY DIVERSE

HUMAN RESPIRATORY SYNCYTIAL VIRUS

MORE DETAILS

0980L90RNP

structurally diverse
Status:
Other
Class:
STRUCTURALLY DIVERSE
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966